Phase 3 Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms: Open-label Extension Phase (GWPCARE7)

Completed · Phase 3

Conditions studied: Infantile Spasms

In brief

This trial consists of 3 parts: a pilot safety phase, a pivotal randomized controlled phase, and an open-label extension phase. The open-label extension phase only will be described in this record. All participants will receive GWP42003-P.

Key facts

Study ID

NCT02954887

Run by

Jazz Pharmaceuticals

People needed

9

Starts

2017-05-12

Expected to finish

2019-06-13

Last updated by the study team

2022-09-02

Who can join

Age: 0 and older, up to 2. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Arkansas Children's Hospital — Little Rock, Arkansas, United States
• Wake Forest Baptist Medical Center — Winston-Salem, North Carolina, United States
• Nationwide Children's Hospital — Columbus, Ohio, United States
• Le Bonheur Children's Hospital — Memphis, Tennessee, United States
• Valley Health Clinical Research — Winchester, Virginia, United States
• Uniwersyteckie Centrum Kliniczne — Gdansk, Poland
• Centrum Medyczne POMOC — Lodz, Poland

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.